Bruker Cellular Analysis, Inc.
CELLDelisted Oct 2, 2023- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001689657
Bruker Cellular Analysis, Inc. was delisted on Oct 2, 2023; its insiders filed their last Form 4 on Oct 3, 2023; 57 institutions reported holding it in 13F filings for Q3 2023, worth $35.8M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Bruker Cellular Analysis, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 117
- +6 vs. Q3 2022
- Shares held
- 48.6M
- +329.2K (+0.7%) vs. Q3 2022
- Total value
- $130.4M
- −$7.73M (−5.6%) vs. Q3 2022
- New holders
- 20
- 44 more added
- Sold out
- 14
- 34 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CELL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 57 | $35.8M |
| Q2 2023 | 84 | $22.1M |
| Q1 2023 | 103 | $63.3M |
| Q4 2022 | 117 | $130.4M |
| Q3 2022 | 113 | $138.4M |
| Q2 2022 | 123 | $244.0M |
| Q1 2022 | 129 | $347.8M |
| Q4 2021 | 132 | $899.0M |
| Q3 2021 | 137 | $953.8M |
| Q2 2021 | 156 | $1.88B |
| Q1 2021 | 156 | $1.89B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Bruker Cellular Analysis, Inc.; share changes are against Q3 2022.